Accelrys Announces Fourth Quarter and Full Year 2011 Financial Results
March 7, 2012
SAN DIEGO-- Accelrys, Inc. (NASDAQ:ACCL) today reported financial results for the quarter and full year ended December 31, 2011. Non-GAAP revenue for the quarter ended December 31, 2011 decreased $1.6 million to $40.8 million from $42.5 million for the same quarter of the previous year, or a decrease of 4%. Non-GAAP revenue for the year [...]
1st DETECT AWARDED EU PATENT FOR CHEMICAL DETECTION TECHNOLOGY
March 7, 2012
Austin, Texas, - 1st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that the European Patent Office (EPO) has issued a key patent for the company's unique method to drive a mass spectrometer ion trap used for chemical analysis and detection. "We are extremely pleased that the EPO has issued this patent, in [...]
Bioo Scientific’s Newest ELISA Facilitates the Screening of Meat Samples for Colistin Contamination
March 7, 2012
Bioo Scientific recently launched the MaxSignal® Colistin ELISA Test Kit for reliable, rapid and cost effective screening of colistin contamination in poultry, beef and pork samples. Austin, TX -- Bioo Scientific has added to its line of simple, quick, and fully quantitative ELISAs designed to screen food and feed samples for antibiotic contamination with the [...]
Sierra Expands Award-Winning Flow Meter Lineup
March 7, 2012
MONTEREY, CA —— Sierra Instruments has just announced that they will be introducing their new SmartTrak® 100 High Pressure mass flow meter at the Pittcon Expo, on March 12 in Orlando at booth #2327. The 100 High Pressure is the latest addition to Sierra’s award-winning SmartTrak 100 and 50 Series of mass flow meters and [...]
March 7, 2012
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Erasmus Medical Center, Rotterdam, Netherlands, has selected the Agilent SureSelect XT Human All Exon target enrichment system along with the Agilent Bravo automated liquid-handling platform as part of the Erasmus Rucphen Family study to identify genetic risk factors for some complex genetic disorders. The [...]
OpGen Completes Growth Capital Financing
March 7, 2012
Gaithersburg, Md.— OpGen, Inc., a commercial stage whole-genome analysis company, announced today that it has reached agreement with new and existing investors to raise up to $17 million in a new growth capital financing. Harris & Harris Group, Inc. and Cross Creek Capital an affiliate of Wasatch Advisors, joined existing investors Highland Capital Partners, Versant [...]
Direct visualisation of cell organelle or sub-cellular structure in real time
March 7, 2012
AMSBIO has announced a new range of ready-to-use lentiviral particles that allow direct visualisation of organelles or structures in cells without manipulation. For real time visualisation, traditionally researchers have had to use plasmids for organelle markers, but the labelling was transitory. Now using the new AMSBIO lentiviral particles - researchers have an easy way to [...]
AB SCIEX Opens New Asia Pacific Application and Training Centre In Singapore’s Biomedical Hub
March 7, 2012
SINGAPORE-- AB SCIEX, a global leader in life science analytical technologies, today announced the opening of its newest Asia Pacific Application and Training Centre. Located in Singapore’s biomedical hub at Biopolis, this centre provides comprehensive service, support and application development to enable the scientific community in Singapore and the rest of ASEAN, Australia, New Zealand, [...]
Professor from Milan Awarded Inaugural Arnold O. Beckman Medal for Electrodriven Separations
March 7, 2012
BREA, CALIF. — Professor Pier Giorgio Righetti of the Polytechnic of Milano Department of Chemistry, Materials and Chemical Engineering was presented with the inaugural Arnold O. Beckman Award and Medal for Outstanding Achievements in the Field of Electrodriven Separations on Monday, February 13th during the 27th International Symposium on MicroScale Bioseparations and Analyses (MSB 2012) [...]
Pall Corporation Second Quarter Sales Increase 8%
March 7, 2012
PORT WASHINGTON, N.Y.,- Pall Corporation (NYSE:PLL) today reported financial results for the second quarter of fiscal year 2012 which ended on January 31, 2012. Second Quarter and Six Months Sales and Earnings Overview Second quarter sales were $698 million, an increase of 8.2% over last year. Sales in local currency ("LC") increased 8.0%. Orders in [...]

